summary
Introduced
03/24/2022
03/24/2022
In Committee
01/03/2023
01/03/2023
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
For legislationfor legislation to expand naloxone access, reports the accompanying bill (Senate, No. 2780).
AI Summary
This bill aims to expand access to naloxone, a drug used to treat opioid overdoses. The key provisions are:
1) Practitioners who prescribe Schedule II opioids must also offer a prescription for an opioid antagonist (such as naloxone) if the patient meets certain conditions, such as being prescribed a high daily dose of opioids or also being prescribed benzodiazepines.
2) Practitioners must provide education to patients on overdose prevention and the use of opioid antagonists.
3) If a practitioner does not co-prescribe an opioid antagonist, they must document the reason or indicate the patient declined the prescription.
4) Practitioners are only required to prescribe an opioid antagonist that has been approved for use by the patient by the FDA.
The goal of this bill is to increase access to naloxone and other opioid overdose reversal drugs, in order to help prevent opioid-related overdoses.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (4)
Other Sponsors (1)
Joint Committee on Public Health (J)
Last Action
New draft substituted, see S3182 (on 01/03/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://malegislature.gov/Bills/192/S2780 |
Bill | https://malegislature.gov/Bills/192/S2780.pdf |
Loading...